Ryan Heit is listed as an executive officer on 2 SEC Form D filings by 1 issuer between Jun 2021 and Apr 2024: Pacylex Pharmaceuticals Inc. (Calgary, Alberta, Canada (as filed: A0) — pharmaceuticals — 2021–2024; $7.18M reported sold to 6 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Ajit Gill (2 shared filings), Cindy Jacobs (2 shared filings), John Mackey (2 shared filings), Luc G. Berthiaume (2 shared filings), Mark Huson (2 shared filings) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ryan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 5 court cases matching the name, 4 state regulator orders, 3 bankruptcy cases matching the name listed in Key records below.
What this means 12 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Ryan Heit and found 2 differences: Form D filed 17 days after the first sale; Address moved from Edmonton, Alberta, Canada (as filed: A0) to Calgary, Alberta, Canada (as filed: A0).
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.